Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Alzheimer's may be treated by targeting gut bacteria and inflammation.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

PSA can help diagnose high androgen levels in women.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Hair loss in young men in Central India is linked to severe heart disease.

Male pattern baldness may predict prostate cancer risk.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.